Josh Riggs insider trades

Open-market stock purchases and sales by Josh Riggs, CEO and President at Insight Molecular Diagnostics Inc, from SEC Form 4 filings since Jan 17, 2023.

Recent trades

DateStockTradeValue
Mar 26, 2026IMDX Insight Molecular Diagnostics IncSold (not open market)$50.6K
Mar 26, 2026IMDX Insight Molecular Diagnostics IncBought (not open market)—

Companies traded

  • IMDX Insight Molecular Diagnostics Inc: other filings, last Mar 26, 2026
  • OCX Oncocyte Corp: 1 buy, last Mar 26, 2025

Get free alerts when Josh Riggs files a new trade →